Original Research
Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone
Journal of Public Health in Africa | Vol 8, No 2 | a968 |
DOI: https://doi.org/10.4081/jphia.2017.732
| © 2024 Nadege G. Mafopa, Gianluca Russo, Raoul E.G. Wadoum, Emmanuel Iwerima, Vincent Batwala, Marta Giovanetti, Antonella Minutolo, Patrick Turay, Thomas B. Turay, Brima Kargbo, Massimo Amicosante, Mattei Maurizio, Carla Montesano
| This work is licensed under CC Attribution 4.0
Submitted: 21 November 2024 | Published: 12 December 2017
Submitted: 21 November 2024 | Published: 12 December 2017
About the author(s)
Nadege G. Mafopa, University of Dschang, Dschang, Cameroon; and, University of Makeni, Makeni, Sierra Leone; and, Holy Spirit Hospital, Maken, Sierra LeoneGianluca Russo, Holy Spirit Hospital, Makeni, Sierra Leone; and, La Sapienza University of Rome, Rome, Italy
Raoul E.G. Wadoum, University of Dschang, Dschang, Cameroon; and, University of Makeni, Makeni, Sierra Leone; and, Holy Spirit Hospital, Makeni, Sierra Leone; and, University of Rome Tor Vergata, Rome, Italy
Emmanuel Iwerima, African Union Support to Ebola Outbreak in West Africa
Vincent Batwala, African Union Support to Ebola Outbreak in West Africa; Directorate of Research and Graduate Training, Mbarara University of Science and Technology, Uganda
Marta Giovanetti, Holy Spirit Hospital, Makeni, Sierra Leone; University of Rome 'Tor Vergata', Rome, Italy
Antonella Minutolo, Holy Spirit Hospital, Makeni, Sierra Leone; University of Rome “Tor Vergata”, Rome
Patrick Turay, Holy Spirit Hospital, Makeni, Sierra Leone
Thomas B. Turay, Partner Relief Development, Freetown, Sierra Leone
Brima Kargbo, Ministry of Health and Sanitation, Freetown, Sierra Leone
Massimo Amicosante, University of Rome 'Tor Vergata', Rome, Italy
Mattei Maurizio, University of Rome 'Tor Vergata', Rome, Italy
Carla Montesano, University of Makeni, Makeni, Sierra Leone; and, Holy Spirit Hospital, Makeni, Sierra Leone; and, University of Rome 'Tor Vergata', Rome, Italy
Full Text:
PDF (614KB)Abstract
A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of the 2013-2016 epidemic in West Africa may cause mild or asymptomatic infection in a proportion of cases, possibly due to an efficient immune response.
Keywords
Ebola; serosurvey; Sierra Leone; seroprevalence
Metrics
Total abstract views: 267Total article views: 81